Lupin Ltd - 500257 - Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2025.

Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Mid-range Performer

1971.8000 16.30 (0.83%)

NSE Nov 07, 2025 15:31 PM

Volume: 3.6M

Lupin Ltd.

06 Nov 2025, 06:30PM

1971.80

0.83%

Result

BSE India

Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2025.

	Sep 2025	Jun 2025	Sep 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	7137.51	6347.38	5715.02	12.4%	24.9%
Operating Profit Qtr	2341.33	1727.24	1340.36	35.6%	74.7%
Net Profit Qtr	1477.92	1219.03	852.63	21.2%	73.3%
Earning Per Share Adjusted latest Qtr	32.36	26.69	18.67	21.2%	73.3%

* Consolidated data

Detailed Results